| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.THROMRES.2012.07.017 |
| P698 | PubMed publication ID | 22909826 |
| P50 | author | Hugo ten Cate | Q37384164 |
| Claude Negrier | Q57033573 | ||
| Yesim Dargaud | Q59167512 | ||
| Valerie Chamouard | Q77401379 | ||
| P2093 | author name string | Trevor Baglin | |
| Alisa S Wolberg | |||
| Thomas Lecompte | |||
| Veronique Regnault | |||
| Henri Spronk | |||
| Roger Luddington | |||
| P433 | issue | 6 | |
| P921 | main subject | automation | Q184199 |
| P304 | page(s) | 929-934 | |
| P577 | publication date | 2012-08-19 | |
| P1433 | published in | Thrombosis Research | Q15758741 |
| P1476 | title | Evaluation of a standardized protocol for thrombin generation measurement using the calibrated automated thrombogram: an international multicentre study | |
| P478 | volume | 130 |
| Q38456897 | A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. |
| Q34209350 | A hereditary bleeding disorder resulting from a premature stop codon in thrombomodulin (p.Cys537Stop) |
| Q89890427 | A new paradigm for personalized prophylaxis for patients with severe haemophilia A |
| Q38845946 | A review of the venous thrombotic issues associated with multiple myeloma |
| Q88670342 | Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency |
| Q26853631 | Achieving and maintaining an optimal trough level for prophylaxis in haemophilia: the past, the present and the future |
| Q37319913 | Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy. |
| Q48237840 | Analytical and between-subject variation of thrombin generation measured by calibrated automated thrombography on plasma samples |
| Q91823045 | Assessment of the analytical performances and sample stability on ST Genesia system using the STG-DrugScreen application |
| Q38776681 | Bioreactivity of stent material: Activation of platelets, coagulation, leukocytes and endothelial cell dysfunction in vitro |
| Q92442794 | Clinical Applications, Pitfalls, and Uncertainties of Thrombin Generation in the Presence of Platelets |
| Q45887437 | Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors--a thrombin generation-guided pilot study |
| Q45884885 | Comparison of thrombin generation assay with conventional coagulation tests in evaluation of bleeding risk in patients with rare bleeding disorders |
| Q56336457 | Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference |
| Q45875113 | Correlation to FVIII:C in Two Thrombin Generation Tests: TGA-CAT and INNOVANCE ETP. |
| Q45862384 | Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements |
| Q36314964 | Disease Severity Correlates with Thrombotic Capacity in Experimental Nephrotic Syndrome |
| Q38710496 | Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β. |
| Q41845013 | Effect of Hemodilution In Vitro with Hydroxyethyl Starch on Hemostasis |
| Q36722757 | Freezing of Apheresis Platelet Concentrates in 6% Dimethyl Sulfoxide: The First Preliminary Study in Turkey. |
| Q33747821 | Generation of Platelet Microparticles after Cryopreservation of Apheresis Platelet Concentrates Contributes to Hemostatic Activity. |
| Q38233155 | Global assays of hemostasis |
| Q35025682 | Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk |
| Q38253173 | Global coagulation assays: a clinical perspective |
| Q36337979 | Global measurement of coagulation in plasma from normal and haemophilia dogs using a novel modified thrombin generation test - Demonstrated in vitro and ex vivo |
| Q43124293 | Global/integral assays in hemostasis diagnostics: promises, successes, problems and prospects. |
| Q50589564 | In vitro effects of dalteparin on thrombin generation in canine plasma. |
| Q58592860 | Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increased VTE occurrence in patients with newly diagnosed multiple myeloma: re |
| Q45864131 | Low agreement between fresh and frozen-thawed platelet-rich plasma in the calibrated automated thrombogram assay |
| Q41118954 | Mechanistic Modeling of the Effects of Acidosis on Thrombin Generation |
| Q45866709 | Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity |
| Q38637310 | Preanalytic processing of rat plasma influences thrombin generation and fibrinolysis assays |
| Q45869234 | Proposal for standardized preanalytical and analytical conditions for measuring thrombin generation in hemophilia: communication from the SSC of the ISTH. |
| Q30840648 | Stability metrics for multi-source biomedical data based on simplicial projections from probability distribution distances. |
| Q41583955 | The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study |
| Q36210410 | Thrombin generation and procoagulant microparticle profiles after acute trauma: A prospective cohort study. |
| Q36818527 | Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. |
| Q40573329 | Thrombin generation assay using factor XIa to measure factors VIII and IX and their glycoPEGylated derivatives is robust and sensitive |
| Q41500303 | Thrombin generation assays for global evaluation of the hemostatic system: perspectives and limitations |
| Q55455218 | Thrombodynamics-A new global hemostasis assay for heparin monitoring in patients under the anticoagulant treatment. |
Search more.